Mouse models for sporadic cancer

R Meuwissen1, J Jonkers, A Berns

  • 1Division of Molecular Genetics and Center of Biomedical Genetics, The Netherlands Cancer Institute, Amsterdam, 1066 CX, The Netherlands.

Insights

Advancements in cancer research utilize sophisticated genetically engineered mouse models. These conditional mouse tumor models enable better understanding of genetic lesions and improved cancer therapy strategies.

Area of Science:

  • Oncology
  • Genetics
  • Animal Models

Background:

  • Significant progress in cancer research over 20 years is linked to enhanced mouse germ line modification capabilities.
  • Early oncomice and tumor-suppressor gene knockout models are evolving into more advanced regulatable and conditional systems.

Purpose of the Study:

  • To review the application of the latest reagents in developing advanced mouse tumor models.
  • To illustrate how conditional mouse models aid in cancer research and therapeutic strategy development.

Main Methods:

  • Review of recent advancements in genetic engineering techniques for mouse models.
  • Discussion of regulatable and conditional mouse tumor model development.

Main Results:

  • Conditional mouse models offer enhanced utility over earlier generations.
  • These models facilitate stronger correlations between genetic alterations and tumor phenotypes.
  • Improved design and validation of cancer therapeutic interventions are possible.

Conclusions:

  • Latest genetic engineering reagents are crucial for developing sophisticated conditional mouse tumor models.
  • These advanced models are instrumental in dissecting cancer biology and optimizing treatment strategies.